Takeda Pharmaceutical (TAK) Exchange Rate Effect (2018 - 2026)

Takeda Pharmaceutical's Exchange Rate Effect history runs 9 years deep, the most recent figure standing at $7.0 million for Q1 2026.

• On a quarterly basis, Exchange Rate Effect rose 111.02% year-over-year to $7.0 million in Q1 2026; TTM through Mar 2026 was $226.7 million, a 374.5% increase from a year earlier, with the FY2026 full-year figure at $229.0 million, up 406.4% from the prior year.
• Exchange Rate Effect slipped to $7.0 million in Q1 2026 per TAK's latest filing, from $145.8 million in the prior quarter.
• Across five years, Exchange Rate Effect topped out at $173.9 million in Q2 2022 and bottomed at -$280.1 million in Q3 2024.
• The 5-year median for Exchange Rate Effect is $71.3 million (2024), against an average of $39.6 million.
• Across the five-year window, Exchange Rate Effect surged 10358.94% in 2022 and tumbled 1111.37% in 2024, its largest moves.
• Year by year, Exchange Rate Effect stood at -$67.8 million in 2022, then jumped by 68.92% to -$21.1 million in 2023, then soared by 814.13% to $150.5 million in 2024, then declined by 3.09% to $145.8 million in 2025, then tumbled by 95.19% to $7.0 million in 2026.
• Per Business Quant, the three latest TAK Exchange Rate Effect figures stand at $7.0 million (Q1 2026), $145.8 million (Q4 2025), and $90.7 million (Q3 2025).